APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 46 filers reported holding APPLIED THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,182,573 | +94.5% | 474,929 | 0.0% | 0.00% | +50.0% |
Q2 2023 | $607,909 | +4.1% | 474,929 | -34.0% | 0.00% | 0.0% |
Q1 2023 | $583,942 | +6.7% | 719,938 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $547,153 | -65.8% | 719,938 | -58.1% | 0.00% | -66.7% |
Q3 2022 | $1,600,000 | -40.5% | 1,719,938 | -39.3% | 0.01% | -45.5% |
Q2 2022 | $2,688,000 | -50.0% | 2,835,000 | +11.2% | 0.01% | -47.6% |
Q1 2022 | $5,378,000 | -46.1% | 2,549,000 | +128.8% | 0.02% | -47.5% |
Q4 2021 | $9,970,000 | -40.8% | 1,114,000 | +9.7% | 0.04% | -45.9% |
Q3 2021 | $16,853,000 | +64.7% | 1,015,271 | +106.1% | 0.07% | +60.9% |
Q2 2021 | $10,234,000 | +82.9% | 492,500 | +65.1% | 0.05% | +76.9% |
Q1 2021 | $5,595,000 | +58.9% | 298,300 | +86.4% | 0.03% | +52.9% |
Q4 2020 | $3,522,000 | +39.5% | 160,000 | +31.6% | 0.02% | +30.8% |
Q3 2020 | $2,525,000 | -69.5% | 121,614 | -46.8% | 0.01% | -75.9% |
Q2 2020 | $8,268,000 | -52.2% | 228,724 | -56.8% | 0.05% | -61.7% |
Q1 2020 | $17,309,000 | – | 529,474 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,032,123 | $17,133,000 | 8.54% |
Orbimed Advisors | 2,257,387 | $37,473,000 | 0.41% |
EMERALD MUTUAL FUND ADVISERS TRUST | 621,317 | $10,314,000 | 0.36% |
EMERALD ADVISERS, LLC | 565,728 | $9,391,000 | 0.34% |
ACT CAPITAL MANAGEMENT, LLC | 37,500 | $623,000 | 0.32% |
Rock Springs Capital Management LP | 701,680 | $11,648,000 | 0.24% |
Artal Group S.A. | 400,000 | $6,640,000 | 0.15% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 639,557 | $10,617,000 | 0.13% |
Point72 Asset Management, L.P. | 1,015,271 | $16,853,000 | 0.07% |
Virtus ETF Advisers LLC | 8,790 | $146,000 | 0.06% |